Staphylococci, Catecholamine Inotropes and Hospital-Acquired Infections

  • Primrose P. E. Freestone
  • Noura Al-Dayan
  • Mark Lyte
Chapter

Abstract

Patients in hospital intensive care units have long been recognized as being at high risk for developing infections from bacteria, fungi, and viruses from within the hospital locality. Risk factors for development of nosocomial infections have usually focussed on the patient’s physical condition and the number and type of invasive medical procedures administered. Using the staphylococci as its focus, this chapter presents recent evidence that some of the medications routinely used in the treatment of acutely ill patients may also be a risk factor for the development of nosocomial infections.

Keywords

Dopamine Norepinephrine Epinephrine Catecholamine Microbe 

References

  1. Baldassarri, L., Bertuccini, L., Ammendolia, M. G., Arciola, C. R., and Montanaro, L. 2001. Effect of iron limitation on slime production by Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 20, 343–345.PubMedGoogle Scholar
  2. Brocard, H. 1940. Production, chez le gobaye, de phlegmons gazeux mortels par l’injection simultanee d’ adrenaline et de cultures de Bacillus perfringes avirulent. C R Seances Soc Biol Fil 134, 567–569.Google Scholar
  3. British National Formulary, 2009. http://www.bnf.org.
  4. Cooper, E. 1946. Gas gangrene following injection of adrenaline. Lancet i, 459–461.CrossRefGoogle Scholar
  5. Crnich, C. J., and Maki, D. G. 2001. The role of intravascular devices in sepsis. Curr Infect Dis Rep 3, 496–506.PubMedCrossRefGoogle Scholar
  6. Crnich ,C. J., and Maki, D. G. 2004. Are antimicrobial-impregnated catheters effective? Don’t throw out the baby with the bathwater. Clin Infect Dis 38, 1287–1292.PubMedCrossRefGoogle Scholar
  7. Deighton, M., and Borland, R. 1993. Regulation of slime production in Staphylococcus epidermidis by iron limitation. Infect Immun 61, 4473–4479.PubMedGoogle Scholar
  8. Evans, D. G., Miles, A. A., and Niven J. S. F. 1948. The enhancement of bacterial infections by adrenaline. Br J Exp Pathol 29, 20–39.PubMedGoogle Scholar
  9. Freestone, P. P. E., Haigh, R. D., Williams, P. H., Lyte, M. 1999. Stimulation of bacterial growth by heat-stable, nor-induced autoinducers. FEMS Microbiol Lett 172, 53–60.PubMedCrossRefGoogle Scholar
  10. Freestone, P. P., Williams, P. H., Haigh, R. D., Maggs, A. F., Neal, C. P., and Lyte, M. 2002. Growth stimulation of intestinal commensal Escherichia coli by catecholamines: a possible contributory factor in trauma-induced sepsis. Shock 18, 465–470.PubMedCrossRefGoogle Scholar
  11. Freestone, P. P., Haigh, R. D., and Lyte, M. 2007. Blockade of catecholamine-induced growth by adrenergic and dopaminergic receptor antagonists in Escherichia coli O157:H7, Salmonella enterica and Yersinia enterocolitica. BMC Microbiol 7, 8.Google Scholar
  12. Freestone, P. P., and Lyte, M. 2008. Microbial endocrinology: experimental design issues in the study of interkingdom signalling in infectious disease. Adv Appl Microbiol 64, 75–105.PubMedCrossRefGoogle Scholar
  13. Freestone, P. P. E., Haigh, R. D., and Lyte, M. 2008. Catecholamine inotrope resuscitation of antibiotic-damaged staphylococci and its blockade by specific receptor antagonists. J Infect Dis 197, 2044–1052.CrossRefGoogle Scholar
  14. Geffers, C., Zuschneid, I., Eckmanns, T., Ruden, H., and Gastmeier, P. 2003. The relationship between methodological trial quality and the effects of impregnated central venous catheters. Intensive Care Med 29, 403–409.PubMedGoogle Scholar
  15. Girbes, A., Pattern, M., McCloskey, B., Groeneveld, A., and Hoogenberg, K. 2000. The renal and neurohumoral effects of the addition of low-dose dopamine in septic critically ill patients. Intensive Care Med 26, 1685–1689.PubMedCrossRefGoogle Scholar
  16. Goldstein, D. S., Eisenhofer, G., and Kopin, I. J. 2003. Sources and significance of plasma levels of catechols and their metabolites in humans. J Pharmacol Exp Ther 305, 800–811.PubMedCrossRefGoogle Scholar
  17. Groves, A. C. et al. 1973. Plasma catecholamines in patients with serious postoperative infection. Ann Surg 178, 102–107.PubMedCrossRefGoogle Scholar
  18. Gruchow, H. W. 1979. Catecholamine activity and infectious disease episodes. J. Human Stress 5, 11–17.PubMedCrossRefGoogle Scholar
  19. Huebner, J., and Goldman, D. A. 1999. Coagulase-negative staphylococci: Role as pathogens. Ann Rev Med 50, 223.PubMedCrossRefGoogle Scholar
  20. Johnston, A. J., Steiner, L. A., O’Connell, M., Chatfield, D. A., Gupta, A. K., and Menon, D. K. 2004. Pharmacokinetics and pharmacodynamics of dopamine and norepinephrine in critically ill head-injured patients. Intensive Care Med 30, 45–50.PubMedCrossRefGoogle Scholar
  21. Lyte, M. 1992. The role of catecholamines in gram-negative sepsis. Med Hypotheses 37, 255–258.PubMedCrossRefGoogle Scholar
  22. Lyte, M. 1993. The role of microbial endocrinology in infectious disease. J Endocrinol 137, 343–345.PubMedCrossRefGoogle Scholar
  23. Lyte, M., Freestone, P. P., Neal, C. P., Olson, B. A., Haigh, R. D., Bayston, R., and Williams, P. H. 2003. Stimulation of Staphylococcus epidermidis growth and biofilm formation by catecholamine inotropes. Lancet 361, 130–135.PubMedCrossRefGoogle Scholar
  24. McConnell, S. A., Gubbins, P. O., and Anaissie, E. J. 2003. Do antimicrobial-impregnated central venous catheters prevent catheter-related bloodstream infection? Clin Infect Dis 37, 65–72.PubMedCrossRefGoogle Scholar
  25. Neal, C. P., Freestone, P. P., Maggs, A. F., Haigh, R. D., Williams, P. H., and Lyte, M. 2001. Catecholamine inotropes as growth factors for Staphylococcus epidermidis and other coagulase-negative staphylococci. FEMS Microbiol Lett 194, 163–169.PubMedCrossRefGoogle Scholar
  26. Ratge, D., Steegmuller, U., Mikus, G., and Kohse, K. P. 1990. Dopamine infusion in healthy subjects and critically ill patients. Clin Exp Pharmacol Physiol 17, 361–369.Google Scholar
  27. Ratledge, C., and Dover, L. G. 2000. Iron metabolism in pathogenic bacteria. Ann Rev Micro 54, 881–941.CrossRefGoogle Scholar
  28. Renaud, M., and Miget, A. 1930. Role favorisant des perturbations locales causees par l’ adrenaline sur le developpement des infections microbiennes. C R Seances Soc Biol Fil 103, 1052–1054.Google Scholar
  29. Sampath, L.A., Tambe, S.M., and Modak, S.M. 2001. In vitro and in vivo efficacy of catheters impregnated with antiseptics or antibiotics: evaluation of the risk of bacterial resistance to the antimicrobials in the catheters. Infect Control Hosp Epidemiol 22, 640–646.PubMedCrossRefGoogle Scholar
  30. Singer, M. 2007. Catecholamine treatment for shock – equally good or bad? Lancet 370, 636–637.PubMedCrossRefGoogle Scholar
  31. Spencer, R.C. 1996. Predominant pathogens found in the European Prevalence of infection in Intensive Care Study. Eur J Clin Microbiol Infect Dis 15, 281–285.PubMedCrossRefGoogle Scholar
  32. Smythe, M. A., Melendy, S., Jahns, B., and Dmuchowski, C. 1993. An exploratory analysis of medication utilization in a medical intensive care unit. Crit Care Med 21, 1319–1323.PubMedCrossRefGoogle Scholar
  33. Vincent, J. L., Bihari, D., and Suter, P. M. 1995. The prevalence of nosocomial infection in intensive care units in Europe: the results of the EPIC study. JAMA 274, 639–644.PubMedCrossRefGoogle Scholar
  34. Zaborina, O., Lepine, F. Xiao, G., Valuckaite, V., Chen, Y., Li, T., Ciancio, M., Zaborin, A., Petrof, E. O., Turner, J. R., Rahme, L. G., Chang, E. and Alverdy, J. C. 2007. Dynorphin activates quorum sensing quinolone signaling in Pseudomonas aeruginosa. PLoS Pathog 3, e35.Google Scholar

Copyright information

© Springer-Verlag New York 2010

Authors and Affiliations

  • Primrose P. E. Freestone
    • 1
  • Noura Al-Dayan
    • 1
  • Mark Lyte
    • 2
  1. 1.Department of Infection, Immunity and InflammationSchool of Medicine, University of LeicesterLeicesterUK
  2. 2.Department of Pharmacy Practice, School of PharmacyTexas Tech University Health Sciences CenterLubbockUSA

Personalised recommendations